Clinipace ranked 260th, moving up 19 spots from 2011 in the prestigious list of fastest-growing American companies
MORRISVILLE, N.C. (Business Wire) August 21, 2012 – Clinipace Worldwide, a global digital clinical research organization (dCRO), has announced that the company has been named to Inc. Magazine’s 31st annual Inc. 500|5000 list. This prestigious list is a compilation of the fastest-growing privately held companies in the country, recognizing their success and potential for the future.
Ranked number 260th overall and 22nd among Inc.’s list of Top Health Companies as a result of 1383% growth over the past three-year period, Clinipace Worldwide is part of an elite company of organizations that have appeared on the list multiple times.
As a global full-service digital CRO, Clinipace Worldwide has pioneered an innovative service model to transform drug and medical device development that serves the unique needs of emerging, venture-backed and mid-tier life sciences firms. With specific expertise developing and executing regulatory strategies, clinical development, and post-approval research, the company has managed over 600 global contract research and regulatory projects.
“We’re honored to have been named to the Inc. 500 list three years in a row,” said Jeff Williams, CEO, Clinipace Worldwide. “The dedication and expertise of our employees has directly contributed to the success of this company. Moving forward, we plan to continue building our global capacity and delivering innovative research services and technology to support growth within our industry.”
This year’s winners will be honored at the 31st Annual Inc. 500|5000 Conference and Awards Ceremony October 3-5 at the Marriott Desert Ridge Resort & Spa in Phoenix, AZ.
About Inc. 500|5000 List
In 1982, Inc. introduced the Inc. 500 list of the fastest-growing privately held companies in the United States. Since then, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark. Oracle, Patagonia, E*Trade, American Apparel, Zipcar and numerous other well-known brands have been honored by the Inc. 500|5000. In 2007, the Inc. 500 list expanded to the Inc. 500|5000, giving readers a deeper, richer understanding of the entrepreneurial landscape and capturing a broader spectrum of success.
Today, the list is a distinguished editorial award, a celebration of innovation, a network of entrepreneurial leaders, and an effective public relations showcase. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. All 5,000 honoree companies are individually profiled on Inc.com. The top 500 are featured in the September issue of Inc. magazine, the leading entrepreneurial advocate for 30 years running. Inc. also ranks the fastest-growing companies by industry, metro area, revenue, and number of employees, and we also highlight women- and minority- run companies.
About Clinipace Worldwide
As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified research model to serve the unique needs of emerging, venture-backed and mid-tier biopharmaceutical and medical device firms. Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 600 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Boulder, Overland Park, Zurich, Munich, Tel-Aviv, Sao Paulo, Buenos Aires, Lima, and New Delhi. For more information, visit our website at www.clinipace.com.